Tumor evaluation and survival
REMISSION
Two months after CCRT, there were 50 patients evaluated with loco‐regional complete remission (CR), and 12 with loco‐regional partial remission (PR) (Table At the last follow‐up on April 9, 2021, the median follow‐up time was 18.7 (range, 7.8–31.7) months. The estimated 1‐year LRFS rate and 1‐year OS were 88.3% and 88.6%, respectively.